Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain.
Saved in:
| Title: | Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain. |
|---|---|
| Authors: | Paesen GC; Division of Structural Biology, Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Chapman NS; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America., Westover JB; Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, Utah, United States of America., McMillen CM; University of Pittsburgh, Center for Vaccine Research, Pittsburgh, Pennsylvania, United States of America.; University of Pittsburgh, Department of Infectious Diseases and Microbiology, School of Public Health, Pittsburgh, Pennsylvania, United States of America., Kuzmina NA; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.; Galveston National Laboratory, Galveston, Texas, United States of America., Dews EA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Myers L; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America., Stass R; Division of Structural Biology, Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Montgomery JM; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.; Galveston National Laboratory, Galveston, Texas, United States of America.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Hartman AL; University of Pittsburgh, Center for Vaccine Research, Pittsburgh, Pennsylvania, United States of America.; University of Pittsburgh, Department of Infectious Diseases and Microbiology, School of Public Health, Pittsburgh, Pennsylvania, United States of America., Gowen BB; Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, Utah, United States of America., Crowe JE Jr; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.; Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America., Bowden TA; Division of Structural Biology, Centre for Human Genetics, University of Oxford, Oxford, United Kingdom. |
| Source: | PLoS pathogens [PLoS Pathog] 2026 Feb 17; Vol. 22 (2), pp. e1013926. Date of Electronic Publication: 2026 Feb 17 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
